- Home
- IMA vs RFM Comparison
IMA vs RFM Comparison
Compare IMA & RFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Current Price
$6.49
Company Overview
Basic Information| Metric | IMA | RFM |
|---|---|---|
| Founded | 2019 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 92.2M | 86.2M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | IMA | RFM |
|---|---|---|
| Price | $6.49 | $14.23 |
| Analyst Decision | Hold | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $16.00 | N/A |
| AVG Volume (30 Days) | ★ 50.1K | 20.7K |
| Earning Date | 11-12-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 9.74% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $800,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $6.19 | $12.89 |
| 52 Week High | $18.00 | $16.41 |
Technical Indicators
Market Signals| Indicator | IMA | RFM |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 52.18 |
| Support Level | N/A | $14.01 |
| Resistance Level | N/A | $14.19 |
| Average True Range (ATR) | 0.00 | 0.14 |
| MACD | 0.00 | 0.01 |
| Stochastic Oscillator | 0.00 | 50.00 |
Price Performance
Historical Comparison IMA
RFM
About IMA ImageneBio Inc.
ImageneBio Inc is a clinical-stage biopharmaceutical company that develops differentiated therapies for immunological and inflammatory (I&I) diseases. The company is focused on developing IMG-007, a non-depleting anti-OX40 monoclonal antibody, for the treatment of atopic dermatitis.
About RFM RiverNorth Flexible Municipal Income Fund Inc.
RiverNorth Flexible Municipal Income Fund Inc is a diversified, closed-end management investment company. Its primary investment objective is to seek current income exempt from regular U.S. federal income taxes. The fund's secondary investment objective is total return.